Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases

Dai, 2013, Probiotics and irritable bowel syndrome, World J. Gastroenterol., 19, 5973, 10.3748/wjg.v19.i36.5973

Khor, 2011, Genetics and pathogenesis of inflammatory bowel disease, Nature, 474, 307, 10.1038/nature10209

Sheil, 2007, Probiotic effects on inflammatory bowel disease, J. Nutr., 137, 819S, 10.1093/jn/137.3.819S

2014, Role of Th17 cells in the pathogenesis of human IBD, ISRN Inflamm., 2014, 928461

Liu, 2009, Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease, J. Gastroenterol., 15, 5784

Chen, 2015, Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis, J. Immunol. Res., 2015, 909514, 10.1155/2015/909514

Sarra, 2010, IL-23/IL-17 axis in IBD, Inflamm. Bowel Dis., 16, 1808, 10.1002/ibd.21248

Sartor, 2006, Mechanisms of disease: Pathogenesis of Crohn’s disease and ulcerative colitis, Nat. Clin. Pract. Gastroenterol. Hepatol., 3, 390, 10.1038/ncpgasthep0528

Klemetti, 2013, Interleukin-17 immunity in paediatric Crohn disease and ulcerative colitis, J. Pediatr. Gastroenterol. Nutr., 57, 287, 10.1097/MPG.0b013e3182979252

Ueno, 2013, Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients, Inflamm. Bowel Dis., 19, 2522, 10.1097/MIB.0b013e3182a85709

Sahin, 2014, Serum interleukin 17 levels in patients with Crohn’s disease: Real life data, Dis. Markers, 2014, 690853, 10.1155/2014/690853

Raza, 2012, Letter: Pathogenicity of Th17 cells may differ in ulcerative colitis compared with Crohn’s disease, Aliment. Pharmacol. Ther., 36, 204, 10.1111/j.1365-2036.2012.05124.x

Ito, 2008, Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice, Biochem. Biophys. Res. Commun., 377, 12, 10.1016/j.bbrc.2008.09.019

Zhang, 2006, Critical role of IL-17 receptor signaling in acute TNBS-induced colitis, Inflamm. Bowel Dis., 12, 382, 10.1097/01.MIB.0000218764.06959.91

Bedoya, 2013, Th17 cells in immunity and autoimmunity, Clin. Dev. Immunol., 2013, 986789, 10.1155/2013/986789

Awasthi, 2009, Th17 cells: From precursors to players in inflammation and infection, Int. Immunol., 21, 489, 10.1093/intimm/dxp021

Tanabe, 2013, The effect of probiotics and gut microbiota on Th17 cells, Int. Rev. Immunol., 32, 511, 10.3109/08830185.2013.839665

Fitzpatrick, 2012, Novel pharmacological approaches for inflammatory bowel disease: Targeting key intracellular pathways and the IL-23/IL-17 axis, Int. J. Inflamm., 2012, 389404

Annunziato, 2008, The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation, Int. Immunol., 20, 1361, 10.1093/intimm/dxn106

Jin, 2013, IL-17 cytokines in immunity and inflammation, Emerg. Microbes Infect., 2, e60, 10.1038/emi.2013.58

Kinugasa, 2000, Claudins regulate the intestinal barrier in response to immune mediators, Gastroenterology, 118, 1001, 10.1016/S0016-5085(00)70351-9

Ogawa, 2004, Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice, Clin. Immunol., 110, 55, 10.1016/j.clim.2003.09.013

Szczepanik, 2011, IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders, Pharmacol. Rep., 63, 30, 10.1016/S1734-1140(11)70396-6

Kamanaka, 2009, A protective function for interleukin 17A in T cell-mediated intestinal inflammation, Nat. Immunol., 10, 603, 10.1038/ni.1736

Yang, 2008, Regulation of inflammatory responses by IL-17F, J. Exp. Med., 205, 1063, 10.1084/jem.20071978

Tanabe, 2008, Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation, Int. J. Mol. Med., 22, 181

Griffin, 2012, IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation, J. Immunol., 15, 6287, 10.4049/jimmunol.1200385

Taylor, 2014, Activation of neutrophils by autocrine IL-17A–IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2, Nat. Immunol., 15, 143, 10.1038/ni.2797

Prause, 2003, Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways, J. Immunol., 170, 4665, 10.4049/jimmunol.170.9.4665

Neurath, 2015, Molecular pathways controlling barrier function in IBD, Nat. Rev. Gastroenterol. Hepatol., 12, 67, 10.1038/nrgastro.2014.201

Hedin, 2007, Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: A review of clinical trials, Proc. Nutr. Soc., 66, 307, 10.1017/S0029665107005563

Miyauchi, 2013, Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: Involvement of intestinal epithelial costimulatory molecules, PLoS ONE, 8, e79735, 10.1371/journal.pone.0079735

Ghadimi, 2012, Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system, J. Leukoc. Biol., 92, 895, 10.1189/jlb.0611286

Dotan, 2007, Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-γ, Am. J. Physiol. Gastrointest. Liver Physiol., 292, G1630, 10.1152/ajpgi.00294.2006

Dubinsky, 2007, IL-23 receptor (IL-23R) gene protects against pediatric Crohn’s disease, Inflamm. Bowel Dis., 13, 511, 10.1002/ibd.20126

Siakavellas, 2012, Role of the IL-23/IL-17 axis in Crohn’s disease, Discov. Med., 14, 253

Bogaert, 2010, Differential mucosal expression of Th17-related genes between the inflamed colon and ileum patients with inflammatory bowel disease, BMC Immunol., 11, 1, 10.1186/1471-2172-11-61

Seiderer, 2008, Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn’s disease and analysis of the IL17F p.His161Arg polymorphism in IBD, Inflamm. Bowel Dis., 14, 437, 10.1002/ibd.20339

Takahashi, 2014, RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis, Nature, 513, 95, 10.1038/nature13706

Sanders, 2013, An update on the use and investigation of probiotics in health and disease, Gut, 62, 787, 10.1136/gutjnl-2012-302504

Spiller, 2008, Review article: Probiotics and prebiotics in irritable bowel syndrome, Aliment. Pharmacol. Ther., 28, 385, 10.1111/j.1365-2036.2008.03750.x

Dagenais, 2013, Crosstalk between the intestinal microbiota and the innate immune system in intestinal homeostasis and inflammatory bowel disease, Inflamm. Bowel Dis., 19, 2227, 10.1097/MIB.0b013e31828dcac7

Abraham, 2011, Interactions between the host innate immune system and microbes in inflammatory bowel disease, Gastroenterology, 140, 1729, 10.1053/j.gastro.2011.02.012

Bien, 2013, The intestinal microbiota dysbiosis and Clostridium difficile infection: Is there a relationship with inflammatory bowel disease?, Ther. Adv. Gastroenterol., 6, 53, 10.1177/1756283X12454590

Shanahan, 2002, Probiotics and inflammatory bowel disease: From fads and fantasy to facts and future, Br. J. Nutr., 88, S5, 10.1079/BJN2002624

Lepage, 2011, Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis, Gastroenterology, 141, 227, 10.1053/j.gastro.2011.04.011

Takaishi, 2008, Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease, Int. J. Med. Microbiol., 298, 463, 10.1016/j.ijmm.2007.07.016

Yoon, 2014, A probiotic preparation duolac-gold ameliorates dextran sulphate sodium-induced mouse colitis by downregulating the expression of IL-6, Toxicol. Res., 30, 27, 10.5487/TR.2014.30.1.027

Heuvelin, 2009, Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors, PLoS ONE, 4, e5184, 10.1371/journal.pone.0005184

Peran, 2006, Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis, Int. J. Colorectal Dis., 21, 737, 10.1007/s00384-005-0773-y

Damaskos, 2008, Probiotics and prebiotics in inflammatory bowel disease: Microflora “on the scope”, Br. J. Clin. Pharmacol., 65, 453, 10.1111/j.1365-2125.2008.03096.x

Ewaschuk, 2006, Probiotics and prebiotics in chronic inflammatory bowel diseases, World J. Gastroenterol., 12, 5941, 10.3748/wjg.v12.i37.5941

Seksik, 2008, Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?, Mol. Nutr. Food Res., 52, 906, 10.1002/mnfr.200700147

Ford, A.C., Quigley, E.M., Lacy, B.E., Lembo, A.J., Saito, Y.A., Schiller, L.R., Soffer, E.E., Spiegel, B.M., and Moayyedi, P. (2014). Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: Systematic review and meta-analysis. Am. J. Gastroenterol., 1547–1561.

Zocco, 2006, Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis, Aliment. Pharmacol. Ther., 23, 1567, 10.1111/j.1365-2036.2006.02927.x

Ishikawa, 2003, Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis, J. Am. Coll. Nutr., 22, 56, 10.1080/07315724.2003.10719276

Bibiloni, 2005, VSL#3 Probiotic-mixture induces remission in patients with active ulcerative colitis, Am. J. Gastroenterol., 100, 1539, 10.1111/j.1572-0241.2005.41794.x

Rembacken, 1999, Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial, Lancet, 354, 635, 10.1016/S0140-6736(98)06343-0

Campieri, 2000, Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn’s disease: A randomized controlled study vs mesalamine, Gastroenterology, 118, A178, 10.1016/S0016-5085(00)85267-1

Guslandi, 2000, Saccharomyces boulardii in maintenance treatment of Crohn’s disease, Dig. Dis. Sci., 45, 1462, 10.1023/A:1005588911207

Prantera, 2002, Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: A randomised controlled trial with Lactobacillus GG, Gut, 51, 405, 10.1136/gut.51.3.405

Schultz, 2004, Lactobacillus GG in inducing and maintaining remission of Crohn’s disease, BMC Gastroenterol., 4, 5, 10.1186/1471-230X-4-5

Bousvaros, 2005, A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease, Inflamm. Bowel Dis., 11, 833, 10.1097/01.MIB.0000175905.00212.2c

Gupta, 2000, Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study, J. Pediatr. Gastroenterol. Nutr., 31, 453

Marteau, 2006, Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: A randomised, double blind, placebo controlled GETAID trial, Gut, 55, 842, 10.1136/gut.2005.076604

Dewit, 2007, Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn’s disease after ileo-caecal resection, Inflamm. Bowel Dis., 13, 135, 10.1002/ibd.20063

Gionchetti, 2003, Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial, Gastroenterology, 124, 1202, 10.1016/S0016-5085(03)00171-9

Mimura, 2004, Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, Gut, 53, 108, 10.1136/gut.53.1.108

Gosselink, 2004, Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG, Dis. Colon Rectum., 47, 876, 10.1007/s10350-004-0525-z

Shen, 2005, Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: Experience in clinical practice, Aliment. Pharmacol. Ther., 22, 721, 10.1111/j.1365-2036.2005.02642.x

Kuisma, 2003, Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora, Aliment. Pharmacol. Ther., 17, 509, 10.1046/j.1365-2036.2003.01465.x

Geier, 2007, Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats, Int. J. Food Microbiol., 114, 267, 10.1016/j.ijfoodmicro.2006.09.018

Zoumpopoulou, 2008, Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models, Int. J. Food Microbiol., 121, 18, 10.1016/j.ijfoodmicro.2007.10.013

Pedrosa, 2009, Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice, Inflamm. Bowel Dis., 15, 1155, 10.1002/ibd.20908

Chen, 2013, Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis, World J. Gastroenterol., 19, 5347, 10.3748/wjg.v19.i32.5347

Sans, 2009, Probiotics for inflammatory bowel disease: A critical appraisal, Dig. Dis., 27, 111, 10.1159/000268130

Rolhion, 2007, Adherent-invasive Escherichia coli in inflammatory bowel disease, Inflamm. Bowel Dis., 13, 1277, 10.1002/ibd.20176

Bartlett, 2007, Clostridium difficile: Old and new observations, J. Clin. Gastroenterol., 41, S24, 10.1097/MCG.0b013e31803d16ec

Venturi, 1999, Impact on the composition of the faecal ora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis, Aliment. Pharmacol. Ther., 13, 1103, 10.1046/j.1365-2036.1999.00560.x

Venkatraman, 2000, Increased permeability in dextran sulphate colitis in rats: Time course of development and effect of butyrate, Scand. J. Gastroenterol., 35, 1053, 10.1080/003655200451171

Claes, 2011, Lessons from probiotic—Host interaction studies in murine models of experimental colitis, Mol. Nutr. Food Res., 55, 1441, 10.1002/mnfr.201100139

Ogita, 2011, Suppression of Th17 response by Streptococcus thermophilus ST28 through induction of IFN-γ, Int. J. Mol. Med., 28, 817

Fitzpatrick, 2010, 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease, Inflamm. Bowel Dis., 16, 1763, 10.1002/ibd.21264

Fitzpatrick, 2012, Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action, J. Pharmacol. Exp. Ther., 342, 850, 10.1124/jpet.112.192203

Iwakura, 2006, The IL-23/IL-17 axis in inflammation, J. Clin. Investig., 116, 1218, 10.1172/JCI28508

Mangan, 2006, Transforming growth factor-β induces development of the Th17 lineage, Nature, 441, 231, 10.1038/nature04754

Kumar, 2008, Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate, J. Gastroenterol. Hepatol., 23, 1834, 10.1111/j.1440-1746.2008.05723.x

Mach, 2006, Clinical usefulness of probiotics, J. Physiol. Pharmacol., 57, 23

Ueno, 2011, Heat-killed body of Lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function, Inflamm. Bowel Dis., 17, 2235, 10.1002/ibd.21597

Lee, 2008, Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice, Int. Immunopharmacol., 8, 574, 10.1016/j.intimp.2008.01.009

Roselli, 2009, Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of γδT and regulatory T cells of intestinal intraepithelial lymphocytes, Inflamm. Bowel Dis., 15, 1526, 10.1002/ibd.20961

Peran, 2007, A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis, Br. J. Nutr., 97, 96, 10.1017/S0007114507257770

Peran, 2005, Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis, World J. Gastroenterol., 11, 5185

Gad, 2011, Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria, FEMS Immunol. Med. Microbiol., 63, 93, 10.1111/j.1574-695X.2011.00835.x

Shida, 2011, Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: A possible mechanism by which probiotics exert multifunctional immune regulatory activities, Gut Microbes, 2, 109, 10.4161/gmic.2.2.15661

Latvala, 2011, Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages, Clin. Exp. Immunol., 165, 94, 10.1111/j.1365-2249.2011.04408.x

Hart, 2004, Modulation of human dendritic cell phenotype and function by probiotic bacteria, Gut, 53, 1602, 10.1136/gut.2003.037325

You, 2012, Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486, FEMS Immunol. Med. Microbiol., 66, 353, 10.1111/j.1574-695X.2012.01014.x

Chen, 2000, Insights from mouse models of colitis, J. Leukoc. Biol., 67, 267, 10.1002/jlb.67.3.267

Annunziato, 2009, Do studies in humans better depict Th17 cells?, Blood, 114, 2213, 10.1182/blood-2009-03-209189

Hershberg, 2000, Antigen processing and presentation by intestinal epithelial cells—Polarity and complexity, Immunol. Today, 21, 123, 10.1016/S0167-5699(99)01575-3

Westendorf, 2009, CD4+ Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells, Gut, 58, 211, 10.1136/gut.2008.151720

Borcherding, 2010, The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease, Am. J. Pathol., 176, 1816, 10.2353/ajpath.2010.090461

Ivanov, 2006, The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035

Yang, 2007, STAT3 regulates cytokine-mediated generation of inflammatory helper T cells, J. Biol. Chem., 282, 9358, 10.1074/jbc.C600321200

Ghadimi, 2010, Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells, Inflamm. Bowel Dis., 16, 410, 10.1002/ibd.21057

Menard, 2004, Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport, Gut, 53, 821, 10.1136/gut.2003.026252

Atarashi, 2010, Induction of lamina propria Th17 cells by intestinal commensal bacteria, Vaccine, 28, 8036, 10.1016/j.vaccine.2010.09.026

Atarashi, 2009, Mechanism of Th17 cell differentiation in the intestinal lamina propria, Inflamm. Regen., 29, 263, 10.2492/inflammregen.29.263